{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T15:39:04Z","timestamp":1770478744822,"version":"3.49.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T00:00:00Z","timestamp":1133395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T00:00:00Z","timestamp":1133395200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Compr Ther"],"published-print":{"date-parts":[[2005,12]]},"DOI":"10.1385\/comp:31:4:284","type":"journal-article","created":{"date-parts":[[2006,1,11]],"date-time":"2006-01-11T14:42:08Z","timestamp":1136990528000},"page":"284-290","source":"Crossref","is-referenced-by-count":11,"title":["Current diagnosis and treatment of lyme disease"],"prefix":"10.1007","volume":"31","author":[{"given":"Robert P.","family":"Smith","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"314284_CR1","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1056\/NEJM200107123450207","volume":"345","author":"AC Steere","year":"2001","unstructured":"Steere AC, Lyme disease. N Engl J Med 2001;345:115\u2013124.","journal-title":"N Engl J Med"},{"key":"314284_CR2","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1172\/JCI200421681","volume":"113","author":"AC Steere","year":"2004","unstructured":"Steere AC, Coburn J, Glickstein L. The emergence of Lyme disease. J Clin Invest 2004;113:1093\u20131101.","journal-title":"J Clin Invest"},{"key":"314284_CR3","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1097\/01.inf.0000145411.57449.f3","volume":"23","author":"JD Cooper","year":"2004","unstructured":"Cooper, JD, Feder MH Jr. Inaccurate information about Lyme disease on the internet. Pediatr Infect Dis J 2004;23:1105\u20131108.","journal-title":"Pediatr Infect Dis J"},{"key":"314284_CR4","doi-asserted-by":"publisher","first-page":"2909","DOI":"10.1073\/pnas.92.7.2909","volume":"92","author":"TG Schwan","year":"1995","unstructured":"Schwan, TG, Piesman J, Golde, WT, et al. Induction of an outer surface protein on Borrelia burgdorferi during tick feeding. Proc Natl Acad Sci USA 1995;92:2909\u20132913.","journal-title":"Proc Natl Acad Sci USA"},{"key":"314284_CR5","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1086\/379039","volume":"188","author":"Z Zhao","year":"2003","unstructured":"Zhao, Z, Chang H, Trevino RP, et al. Selective up-regulation of matrix metall oproteinase-9 expression in human erythema migrans skin lesions of acute Lyme disease. J Infect Dis 2003;188:1098\u20131104.","journal-title":"J Infect Dis"},{"key":"314284_CR6","doi-asserted-by":"crossref","first-page":"751","DOI":"10.7326\/0003-4819-142-9-200505030-00011","volume":"142","author":"GP Wormser","year":"2005","unstructured":"Wormser, GP, McKenna D, Carlin J, et al. Brief communication: Hematogenous dissemination in early Lyme disease. Ann Intern Med 2005;142:751\u2013755.","journal-title":"Ann Intern Med"},{"key":"314284_CR7","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1086\/339341","volume":"185","author":"D Lusitani","year":"2002","unstructured":"Lusitani, D, Malawista SE, Montgomery, RR. Borrelia burgdorferi are susceptible to killing by a variety of human polymorphonuclear leukocyte components. J Infect Dis 2002;185:797\u2013804.","journal-title":"J Infect Dis"},{"key":"314284_CR8","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1086\/322669","volume":"33","author":"RA Kalish","year":"2001","unstructured":"Kalish, RA, McHugh G, Granquist J, et al. Persistence of immunoglobulin M or immunoglobulin G antibody responses to Borrelia burgdorferi 10\u201320 years after active Lyme disease. Clin Infec Dis 2001;33:780\u2013785.","journal-title":"Clin Infec Dis"},{"key":"314284_CR9","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1056\/NEJM199610243351703","volume":"335","author":"MA Gerber","year":"1996","unstructured":"Gerber MA, Shapiro Ed, Burke GS, et al. Lyme disease in children in southern Connecticut. Pediatric Lyme Disease Study Group. N Eng J Med 1996;335:1270\u20131274.","journal-title":"N Eng J Med"},{"key":"314284_CR10","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1056\/NEJM199807233390401","volume":"339","author":"AC Steere","year":"1998","unstructured":"Steere AC, Sikand VK, Meurice F, et al. Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface lipoprotein A with adjuvant. N Engl J Med 1998;339:209\u2013215.","journal-title":"N Engl J Med"},{"key":"314284_CR11","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/S0002-9343(95)99915-9","volume":"100","author":"RB Nadelman","year":"1996","unstructured":"Nadelman RB, Nowakowski J, Forester, Gilda, et al. The clinical spectrum of early Lyme borreliosis in patients with cultureconfirmed erythema migrans. Am J Med 1996;100:502\u2013508.","journal-title":"Am J Med"},{"key":"314284_CR12","doi-asserted-by":"crossref","first-page":"421","DOI":"10.7326\/0003-4819-136-6-200203190-00005","volume":"136","author":"RP Smith","year":"2002","unstructured":"Smith RP, Schoen RT, Rahn DW, et al. Clinical characteristics and treatment outcome of early Lyme disease in patients with microbiologically confirmed erythema migrans. Ann Intern Med 2002;136:421\u2013428.","journal-title":"Ann Intern Med"},{"key":"314284_CR13","doi-asserted-by":"crossref","first-page":"76","DOI":"10.7326\/0003-4819-99-1-76","volume":"9","author":"AC Steere","year":"1983","unstructured":"Steere AC, Barthenhagen NH, Craft JE, et al. The early clinical manifestations of Lyme disease. Ann Intern Med 1983;9:76\u201382.","journal-title":"Ann Intern Med"},{"key":"314284_CR14","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1093\/infdis\/172.2.470","volume":"272","author":"GL Campbell","year":"1995","unstructured":"Campbell GL, Paul WS, Schriefer ME, Craven RB, Robbins KE, Dennis DT. Epidemiologic and diagnostic studies of patients with suspected early Lyme disease in Missouri. J Infect Dis 1995; 272:470\u2013480.","journal-title":"J Infect Dis"},{"key":"314284_CR15","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1086\/427289","volume":"40","author":"GP Wormser","year":"2005","unstructured":"Wormser GP, Masters E, Liveris D, et al. Microbiologic evaluation of patients from Missouri with erythema migrans. Clin Infect Dis 2005;40:423\u2013428.","journal-title":"Clin Infect Dis"},{"key":"314284_CR16","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/S0002-9343(02)01440-7","volume":"114","author":"AC Steere","year":"2003","unstructured":"Steere AC, Hernandez J, Sikand VK, Nowakowski J, Persing DH. Systemic symptoms without erythema migrans as the presenting picture of early Lyme disease. Am J Med 2003;114:58\u201361.","journal-title":"Am J Med"},{"key":"314284_CR17","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1086\/376914","volume":"37","author":"AC Steere","year":"2003","unstructured":"Steere AC, Sikand VK, Schoen RT, Nowakowski J. Asymptomatic infection with Borrelia burgdorferi. Clin Infec Dis 2003;37:528\u2013532.","journal-title":"Clin Infec Dis"},{"issue":"part 1","key":"314284_CR18","doi-asserted-by":"crossref","first-page":"8","DOI":"10.7326\/0003-4819-93-1-8","volume":"93","author":"AC Steere","year":"1980","unstructured":"Steere AC, Batsford WP, Weinberg M, et al. Lyme carditis: cardiac abnormalities of Lyme disease. Ann Intern Med 1980;93(part 1): 8\u201316.","journal-title":"Ann Intern Med"},{"key":"314284_CR19","doi-asserted-by":"crossref","first-page":"339","DOI":"10.7326\/0003-4819-110-5-339","volume":"110","author":"HF McAlister","year":"1989","unstructured":"McAlister HF, Klementowicz PT, Andrews C et al. Lyme carditis: an important cause of reversible heart block. Ann Intern Med 1989;110:339\u2013345.","journal-title":"Ann Intern Med"},{"key":"314284_CR20","doi-asserted-by":"crossref","first-page":"346","DOI":"10.7326\/0003-4819-128-5-199803010-00002","volume":"128","author":"O Sangha","year":"1998","unstructured":"Sangha O, Phillips CB, Fleischmann KE, et al. Lack of cardiac manifestations among patients with previously treated Lyme disease. Ann Intern Med. 1998;128:346\u2013353.","journal-title":"Ann Intern Med."},{"key":"314284_CR21","first-page":"143","volume":"4","author":"AC Steere","year":"2004","unstructured":"Steere AC, Glickstein L Elucidation of Lyme arthritis. Immunology 2004;4:143\u2013152.","journal-title":"Immunology"},{"key":"314284_CR22","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/00005792-197907000-00001","volume":"58","author":"L Reik","year":"1979","unstructured":"Reik L, Steere AC, Bartengagen NH, Shope, RE, Malawista SE, Neurologic abnormalities of Lyme disease. Medicine (Baltimore) 1979;58:281\u2013294.","journal-title":"Medicine (Baltimore)"},{"key":"314284_CR23","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1212\/WNL.37.11.1700","volume":"37","author":"J Halpern","year":"1986","unstructured":"Halpern J, Little BW, Coyle PK, Dattwyler RS, Lyme disease: cause of a peripheral neuropathy. Neurology 1986; 37:1700\u20131706.","journal-title":"Neurology"},{"key":"314284_CR24","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1056\/NEJM199011223232102","volume":"323","author":"EL Logigian","year":"1990","unstructured":"Logigian EL, Kaplan RF, Steere AC. Chronic neurologic manifestations of Lyme disease. N Eng J Med 1990;323:1438\u20131444.","journal-title":"N Eng J Med"},{"key":"314284_CR25","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1086\/322681","volume":"33","author":"C Thompson","year":"2001","unstructured":"Thompson C, Spielman A, Krause PJ. Coinfecting deer-associated zoonoses: Lyme disease, babesiosis, and ehrlichiosis. Clin Infec Dis 2001;33:676\u2013684.","journal-title":"Clin Infec Dis"},{"key":"314284_CR26","first-page":"596","volume":"44","author":"Recommendations for test performance and interpretation from the Second National Conference on Serologic Diagnosis of Lyme disease","year":"1995","unstructured":"Recommendations for test performance and interpretation from the Second National Conference on Serologic Diagnosis of Lyme disease. MMWR Morb Mortal Wkly Rep 1995;44:596\u2013601.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"314284_CR27","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1128\/jcm.35.3.537-543.1997","volume":"35","author":"Li Bakken","year":"1997","unstructured":"Bakken Li, Callister SM, Ward PJ, et al. Interlaboratory comparison of test results for detection of Lyme disease by 516 participants in the Wisconsin State Laboratory of Hygiene\/College of American Pathologists Proficiency Testing Program. J Clin Microbiol 1997;35:537\u2013543.","journal-title":"J Clin Microbiol"},{"key":"314284_CR28","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1086\/374395","volume":"186","author":"RM Bacon","year":"2003","unstructured":"Bacon RM, Biggerstaff BJ, Schriefer ME, et al. Serodiagnosis of Lyme disease by kinetic enzyme-liked immunosorbent assay using recombinant VlsE1 or peptide antigens of Borrelia burgdorferi compared with 2-tiered testing using whole-cell lysates. J Infect Dis 2003;186:1187\u20131198.","journal-title":"J Infect Dis"},{"key":"314284_CR29","first-page":"924","volume":"11.5","author":"E Mogilyansky","year":"2004","unstructured":"Mogilyansky E, Loa CC, Adelson ME, Mordechai E, Tilton RC. Comparison of western immunoblotting and the C6 Lyme antibody test for laboratory detection of Lyme disease. CDLI 2004; 11.5:924\u2013929.","journal-title":"CDLI"},{"key":"314284_CR30","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/infdis\/154.2.295","volume":"154","author":"AC Steere","year":"1986","unstructured":"Steere AC, Taylor E, Wilson ML, Levine JF, Spielman A. Longitudinal assessment of the clinical and epidemiological features of Lyme disease in a defined population. J Infec Dis 1986;154: 295\u2013300.","journal-title":"J Infec Dis"},{"key":"314284_CR31","unstructured":"Notice to readers: caution regarding testing for Lyme disease. MMWR Morb Mortal Wkly Rep 2005;54:125"},{"issue":"Suppl 1","key":"314284_CR32","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1086\/314053","volume":"31","author":"GP Wormser","year":"2000","unstructured":"Wormser GP, Nadelman RB, Dattwyler RJ, et al. Practice guidelines for the treatment of Lyme disease. Clin Infec Dis 2000;31(Suppl 1): S1-S14.","journal-title":"Clin Infec Dis"},{"key":"314284_CR33","doi-asserted-by":"crossref","first-page":"697","DOI":"10.7326\/0003-4819-138-9-200305060-00005","volume":"138","author":"GP Wormser","year":"2003","unstructured":"Wormser GP, Ramanthan R, Nowakowski J, et al. Duration of antibiotic therapy for early Lyme disease. Ann Intern Med 2003;138:697\u2013704.","journal-title":"Ann Intern Med"},{"key":"314284_CR34","first-page":"661","volume":"39","author":"SW Luger","year":"1995","unstructured":"Luger SW, Paparone P, Wormser GP, et al. Comparison of cefuroxime axetil and doxycycline in treatment of patients with early Lyme disease associated with erythema migrans. Am Soc Microb 1995;39:661\u2013667.","journal-title":"Am Soc Microb"},{"key":"314284_CR35","doi-asserted-by":"crossref","first-page":"273","DOI":"10.7326\/0003-4819-117-4-273","volume":"1176","author":"RB Nadelman","year":"1992","unstructured":"Nadelman RB, Luger SW, Frank E, et al. Comparison of cefuroxime axetil and doxycycline in the treatment of early Lyme disease. Ann Intern Med 1992;1176:273\u2013280.","journal-title":"Ann Intern Med"},{"key":"314284_CR36","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1056\/NEJM199707313370501","volume":"337","author":"RJ Dattwyler","year":"1997","unstructured":"Dattwyler RJ, Luft BJ, Kunkel MJ, et al. Cefriaxone compared with doxycycline for the treatment of acute disseminated Lyme disease. N Eng J Med 1997;337:289\u2013294.","journal-title":"N Eng J Med"},{"key":"314284_CR37","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1086\/515145","volume":"28","author":"L Dovevall","year":"1999","unstructured":"Dovevall L, Hagberg L. Successful oral doxycycline treatment of Lyme disease-associated facial palsy and meningitis. Clin Infec Dis 1999;28:569\u2013574.","journal-title":"Clin Infec Dis"},{"key":"314284_CR38","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1086\/314860","volume":"180","author":"EL Logigian","year":"1999","unstructured":"Logigian EL, Kaplan RF, Steere AC. Successful treatment of Lyme encephalopathy with intravenous ceftriaxone. J Infect Dis 1999;180:377\u2013383.","journal-title":"J Infect Dis"},{"key":"314284_CR39","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1056\/NEJM200107123450202","volume":"345","author":"MS Klempner","year":"2001","unstructured":"Klempner MS, Linden MD, Hu T, et al. Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease. N Engl J Med 2001; 345:85\u201392.","journal-title":"N Engl J Med"},{"key":"314284_CR40","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1212\/01.WNL.0000071227.23769.9E","volume":"60","author":"LB Krupp","year":"2003","unstructured":"Krupp LB, Hyman LG, Grimson R, et al. Study and treatment of post Lyme disease (STOP-LD). Neurology 2003;60:1923\u20131930.","journal-title":"Neurology"},{"key":"314284_CR41","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1089\/153036602321653842","volume":"2","author":"MS Klempner","year":"2002","unstructured":"Klempner MS. Controlled trials of antibiotic treatment in patients with post-treatment chronic Lyme disease. Vector Borne and Zoonotic Dis 2002;2:255\u2013263.","journal-title":"Vector Borne and Zoonotic Dis"},{"key":"314284_CR42","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1001\/jama.283.5.609","volume":"283","author":"EG Seltzer","year":"2000","unstructured":"Seltzer, EG, Gerber MA, Cartter ML, Freudigman K, Shapiro ED. Long-term outcomes of persons with Lyme disease. JAMA 2000;283:609\u2013615.","journal-title":"JAMA"},{"key":"314284_CR43","doi-asserted-by":"crossref","first-page":"919","DOI":"10.7326\/0003-4819-131-12-199912210-00003","volume":"131","author":"NA Shadick","year":"1999","unstructured":"Shadick NA, Phillips CB, Sangha, O., et al. Musculoskeletal and neurologic outcomes in patients with previously treated Lyme disease. Ann Intern Med. 1999;131:919\u2013926.","journal-title":"Ann Intern Med."},{"key":"314284_CR44","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/S0002-9343(03)00308-5","volume":"115","author":"J Nowakowski","year":"2003","unstructured":"Nowakowski J, Nadelman RB, Sell, R, et al. Long-term follow-up of patients with culture-confirmed Lyme disease. Am J Med. 2003;115:91\u201396.","journal-title":"Am J Med."},{"key":"314284_CR45","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1086\/318082","volume":"183","author":"RA Kalish","year":"2001","unstructured":"Kalish, RA, Kaplan RF, Taylor E, Jones-Woodward L, Workman K, Steere AC, Evaluation of study patients with Lyme disease, 10\u201320-year follow-up. J Infec Dis 2001;183:453\u2013460.","journal-title":"J Infec Dis"},{"key":"314284_CR46","doi-asserted-by":"crossref","unstructured":"Hayes EB, Piesman J. How can we prevent Lyme disease? N Engl J Med 348:2424\u20132430.","DOI":"10.1056\/NEJMra021397"},{"key":"314284_CR47","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1056\/NEJM200107123450201","volume":"345","author":"RB Nadelman","year":"2001","unstructured":"Nadelman RB, Nowakowski J, Fish D, et al. Prophylaxis with singledose doxycycline for the prevention of Lyme disease after an Ixodes scapularis tick bite. N Engl J Med 2001;345:79\u201384.","journal-title":"N Engl J Med"},{"key":"314284_CR48","first-page":"606","volume-title":"Medical Management of Infectious Disease","author":"RP Smith","year":"2003","unstructured":"Smith RP. Tick-borne infections. In: Medical Management of Infectious Disease (Grace C ed.). Marcel Dekker, New York, 2003, pp. 606\u2013607."}],"container-title":["Comprehensive Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1385\/COMP:31:4:284.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1385\/COMP:31:4:284\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1385\/COMP:31:4:284","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1385\/COMP:31:4:284.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T13:20:03Z","timestamp":1744032003000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1385\/COMP:31:4:284"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12]]},"references-count":48,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["314284"],"URL":"https:\/\/doi.org\/10.1385\/comp:31:4:284","relation":{},"ISSN":["0098-8243","1559-1190"],"issn-type":[{"value":"0098-8243","type":"print"},{"value":"1559-1190","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,12]]}}}